Filters

STAT5b(Ser731) Antibody, Cy7 Conjugated

STAT5b(Ser731) Antibody, Cy7 Conjugated size: 0.1ml 368

Price 368
Size 0.1ml
Long name Cy7 Conjugated, STAT5b(Ser731) Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenSTAT5b Ser731
SpecificityThis is a highly specific antibody against STAT5b Ser731
ModificationPhosphorylation
Modification siteSer731
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic phosphopeptide derived from human STAT5b around the phosphorylation site of Ser731
Gene ID number6777
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Binds to the GAS element and activates PRL-induced transcription, Carries out a dual function: signal transduction and activation of transcription
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms STA5B_HUMAN, STAT5, Signal transducer and activator of transcription 5B, Stat5b, Transcription factor STAT5B, STAT5bphospho S731
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetSTAT5b(Ser731) Conjugated
Short name Conjugated, STAT5b(Ser731) Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, signal transducer and activator on transcription 5B(Ser731) (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter